Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Collagen Matrix launches composite bone graft material for orthopaedic and spine applications

Collagen Matrix : 23 October, 2007  (New Product)
Collagen Matrix has launched the company’s OssiMend Bone Graft Matrix, an all-natural mineral-collagen composite bone graft material, to address orthopaedic and spine applications.
OssiMend when combined with autologous bone marrow, is used to fill bony voids or gaps of the skeletal system, including spine, extremities and pelvis. OssiMend is conformable, non-friable, has a high absorption capacity, and is ideal for use in spine fusion procedures.

OssiMend is a composite matrix available in strips, pads, or granular form for surgical implantation. The principle components of OssiMend are type I collagen and anorganic bone mineral. The natural anorganic bone mineral is derived from bovine cancellous and cortical bone. Due to its natural structure, OssiMend is physically and chemically comparable to the mineralised matrix of human bone.

The mineral particles are dispersed within highly purified type I collagen fibres forming a three-dimensional open porous matrix for use as an osteoconductive material. The addition of autologous bone marrow further enhances the bone forming capability of the product from bone inductive factors and bone forming cells in the bone marrow.

OssiMend is provided as a sterile, dry material that is hydrated with autologous bone marrow at the point of use. OssiMend strips and pads can be cut into shapes and are designed to retain their shape and physical integrity following implantation into a bony site, while the granular form can be moulded to fit the bone defect. The product is fully resorbed during the natural process of bone formation and remodelling.

“Early launch sales of OssiMend via independent sales agents have been better than expected. Feedback from surgeons has been very positive,” said Shu-Tung Li, PhD, founder and CEO, Collagen Matrix.

“Along with OssiMend, we are introducing a Multi-port Bone Marrow Aspiration Needle to aid in the harvest of autologous bone marrow. Additional products for the orthopaedic-spine market, including OssiGuide Anorganic Bone Mineral Granules and DuraMatrix-Spine Onlay, are planned for commercialisation in the coming months.”
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo